EKSO Stock Price, Chart, Stats & News

Ekso Bionics Holdings, Inc.
Save
61.93M
Market cap
–
Current P/E
–
Forward P/E
EKSO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 53.48% |
Operating margin | -104.12% |
Pretax margin | -91.37% |
Net margin | -91.37% |
Effective tax rate | – |
ROA | -58.15% |
ROE | -110.52% |
D/E | 0.29x |
Interest coverage ratio | -21.53x |
EKSO valuation
P/E | – |
P/S | 1.92x |
P/B | 2.73x |
P/CF | -2.09x |
P/FCF | -2.09x |
P/OCF | -2.09x |
PEG | 0.03x |
EV multiple | -2.20x |
About
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted.
Similar securities
Based on sector and market capitalization
Report issue











